Guangzhou Patronus Biotech Co., Ltd.
Quick facts
Phase 3 pipeline
- ZF2001 · Diabetes
ZF2001 is a small molecule that targets the SGLT2 receptor.
Phase 1 pipeline
- LYB002CA
- LYB002V14
- LYB002V14A
- LYB004 25µg
- LYB004 50µg
- LYB005 high dose with adjuvant
- LYB005 high dose without adjuvant
- LYB005 low dose with adjuvant
- LYB005 low dose without adjuvant
- LYB005 middle dose with adjuvant
- LYB005 middle dose without adjuvant
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: